StockData
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF

NOVO NORDISK A S

Financials through fiscal 2025, year ended Dec 31, 2025
$38.42−0.41 (-1.06%)

Close on Oct 19, 2026

NOVO NORDISK A S revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Novo Nordisk A S does not break out revenue by segment, region or product in the tagged data of its filings for this period type.